var data={"title":"Dextromethorphan poisoning: Treatment","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Dextromethorphan poisoning: Treatment</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/contributors\" class=\"contributor contributor_credentials\">Chris Rosenbaum, MD, MSc, FACEP</a></dd><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/contributors\" class=\"contributor contributor_credentials\">Edward W Boyer, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/contributors\" class=\"contributor contributor_credentials\">Michele M Burns, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/contributors\" class=\"contributor contributor_credentials\">James F Wiley, II, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning will be reviewed here. The epidemiology, pertinent pharmacology, and clinical features of dextromethorphan poisoning are discussed separately. (See <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;</a>.)</p><p>Related issues such as methylenedioxymethamphetamine (MDMA) abuse, serotonin syndrome, anticholinergic poisoning, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> intoxication, phencyclidine (PCP) intoxication, ethanol intoxication, and a general approach to management of the poisoned patient are presented elsewhere. (See <a href=\"topic.htm?path=mdma-ecstasy-intoxication\" class=\"medical medical_review\">&quot;MDMA (ecstasy) intoxication&quot;</a> and <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a> and <a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">&quot;Anticholinergic poisoning&quot;</a> and <a href=\"topic.htm?path=ketamine-poisoning\" class=\"medical medical_review\">&quot;Ketamine poisoning&quot;</a> and <a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Phencyclidine (PCP) intoxication in children and adolescents&quot;</a> and <a href=\"topic.htm?path=ethanol-intoxication-in-children-clinical-features-evaluation-and-management\" class=\"medical medical_review\">&quot;Ethanol intoxication in children: Clinical features, evaluation, and management&quot;</a> and <a href=\"topic.htm?path=general-approach-to-drug-poisoning-in-adults\" class=\"medical medical_review\">&quot;General approach to drug poisoning in adults&quot;</a> and <a href=\"topic.htm?path=approach-to-the-child-with-occult-toxic-exposure\" class=\"medical medical_review\">&quot;Approach to the child with occult toxic exposure&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1114943080\"><span class=\"h1\">CLINICAL FEATURES AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical features and diagnosis of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning are discussed separately. (See <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">SUPPORTIVE CARE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Recommendations for care of children and adults with <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning are derived from case series and reports and are driven by physical findings. The treatment of dextromethorphan poisoning is primarily supportive. (See <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis#H9\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;, section on 'Clinical features'</a>.)</p><p>In addition, to careful assessment and support of airway, breathing, and circulation as needed, the clinician should anticipate and aggressively manage dissociative signs and symptoms (eg, psychosis, hallucinations, agitation), hyperthermia, rhabdomyolysis, and dehydration [<a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/1-4\" class=\"abstract_t\">1-4</a>]. Specific antidotal therapy may be necessary for patients who manifest coma and respiratory depression, serotonin syndrome, or concomitant anticholinergic poisoning. (See <a href=\"#H8\" class=\"local\">'Naloxone'</a> below and <a href=\"#H9\" class=\"local\">'Other toxins'</a> below.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Restraint and sedation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Early management of agitation or violent behavior is essential to prevent patient and staff injury. The emergency provider should exclude life-threatening hypoglycemia and hypoxia as contributing factors to agitation as soon as is safely possible. Verbal reassurance and placement of the patient in a calm, quiet, and subdued environment may suffice in the adolescent or adult with mild to moderate <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> intoxication.</p><p>In the markedly agitated or floridly psychotic patient, initial control often requires supine physical restraint that is rapidly followed by sedation with intravenous or intramuscular benzodiazepines (eg, <a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a> 0.1 <span class=\"nowrap\">mg/kg;</span> maximum initial dose: 2 mg, repeat in 10 to 30 minutes as needed). Parenteral neuroleptic medication (eg, <a href=\"topic.htm?path=haloperidol-drug-information\" class=\"drug drug_general\">haloperidol</a>) should be avoided in patients with <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> overdose because it may exacerbate hyperthermia or anticholinergic symptoms. (See <a href=\"topic.htm?path=assessment-and-emergency-management-of-the-acutely-agitated-or-violent-adult\" class=\"medical medical_review\">&quot;Assessment and emergency management of the acutely agitated or violent adult&quot;</a> and <a href=\"topic.htm?path=emergency-department-evaluation-of-acute-onset-psychosis-in-children#H20\" class=\"medical medical_review\">&quot;Emergency department evaluation of acute onset psychosis in children&quot;, section on 'Physical restraint and sedation'</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Hyperthermia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Active cooling measures should be instituted promptly in patients with elevated rectal temperature and with other findings that indicate malignant hyperthermia (eg, pulmonary edema, rhabdomyolysis). (See <a href=\"topic.htm?path=severe-nonexertional-hyperthermia-classic-heat-stroke-in-adults#H2989359854\" class=\"medical medical_review\">&quot;Severe nonexertional hyperthermia (classic heat stroke) in adults&quot;, section on 'Diagnosis'</a>.)</p><p>Augmentation of evaporative cooling is considered the treatment of choice because it is effective, noninvasive, and easily performed. The naked patient is sprayed with a mist of lukewarm water while air is circulated with large fans. Shivering may be suppressed with intravenous benzodiazepines such as <a href=\"topic.htm?path=diazepam-drug-information\" class=\"drug drug_general\">diazepam</a> (5 mg IV) or <a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a> (1 to 2 mg IV). Cold inspired oxygen, cold gastric lavage, cooling blankets, and cold intravenous fluids may be helpful adjuncts. (See <a href=\"topic.htm?path=severe-nonexertional-hyperthermia-classic-heat-stroke-in-adults#H10\" class=\"medical medical_review\">&quot;Severe nonexertional hyperthermia (classic heat stroke) in adults&quot;, section on 'Management'</a> and <a href=\"topic.htm?path=heat-stroke-in-children#H18\" class=\"medical medical_review\">&quot;Heat stroke in children&quot;, section on 'Rapid cooling'</a>.)</p><p>Some experts advocate that patients with marked hyperthermia (temperature &gt;40&deg;C) might benefit from rapid sequence intubation followed by prolonged paralysis to stop heat generation from muscle activity.</p><p>There is NO ROLE for antipyretic agents such as <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> or <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> in the management of drug-induced hyperthermia, since the underlying mechanism does not involve a change in the hypothalamic temperature set-point. Alcohol sponge baths should also be avoided because large amounts of the isopropyl alcohol may be absorbed through dilated cutaneous vessels and produce toxicity</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Rhabdomyolysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperthermia, agitation, seizures, and muscle rigidity may lead to muscle cell breakdown (rhabdomyolysis) with significant risk for renal failure. Patients with rhabdomyolysis typically present with the triad of pigmented granular casts in the urine, a red to brown color of the urine supernatant, and a marked elevation in the plasma level of creatine kinase (CK). Primary treatment goals consist of (see <a href=\"topic.htm?path=prevention-and-treatment-of-heme-pigment-induced-acute-kidney-injury\" class=\"medical medical_review\">&quot;Prevention and treatment of heme pigment-induced acute kidney injury&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fluid repletion with normal saline infusion (20 to 40 <span class=\"nowrap\">mL/kg</span> per hour up to 1 to 2 L per hour); the emergency provider should closely monitor urine output with the goal of maintaining a minimum urine flow of 4 <span class=\"nowrap\">mL/kg</span> per hour; 200 mL per hour in adults. Once diuresis is established, alkalinization of the urine and <a href=\"topic.htm?path=mannitol-drug-information\" class=\"drug drug_general\">mannitol</a> diuresis is commonly employed but efficacy is uncertain.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation for significant electrolyte abnormalities (hyperkalemia, hyperphosphatemia, and hypocalcemia); management of hyperkalemia is of particular importance. Hypocalcemia is usually transient and calcium administration should be avoided unless severe symptoms (eg, tetany) are present.</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Serotonin syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to supportive care aimed at agitation and hyperthermia as described above, patients suspected of serotonin syndrome frequently require aggressive sedation with benzodiazepines (<a href=\"image.htm?imageKey=EM%2F73400\" class=\"graphic graphic_table graphicRef73400 \">table 1</a>). In severe cases, serotonin receptor blockade with <a href=\"topic.htm?path=cyproheptadine-drug-information\" class=\"drug drug_general\">cyproheptadine</a> may be indicated. (See <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a>.)</p><p>Seizures are best managed with a benzodiazepine (eg, 0.1 <span class=\"nowrap\">mg/kg</span> <a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a>, maximum dose: 2 mg; repeat every 2 to 3 minutes up to three doses). <a href=\"topic.htm?path=phenobarbital-drug-information\" class=\"drug drug_general\">Phenobarbital</a> in an initial dose of 15 to 20 is preferred to <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a> as second line treatment if seizures persist. (See <a href=\"topic.htm?path=management-of-convulsive-status-epilepticus-in-children\" class=\"medical medical_review\">&quot;Management of convulsive status epilepticus in children&quot;</a> and <a href=\"topic.htm?path=convulsive-status-epilepticus-in-adults-classification-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">GASTROINTESTINAL DECONTAMINATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> and other components of over-the-counter (OTC) cough medications bind well to activated charcoal (AC), the primary means of decontamination in overdose.</p><p>We suggest that patients who ingest dextromethorphan-containing medicines and who present within one hour of known or suspected ingestion receive AC (1 <span class=\"nowrap\">g/kg,</span> maximum dose 50 g) by mouth or nasogastric tube. AC should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should <strong>not</strong> be performed solely for the purpose of giving AC. The greatest benefit occurs if AC is given within one hour. The efficacy of AC as a function of time from ingestion is discussed in detail separately. (See <a href=\"topic.htm?path=gastrointestinal-decontamination-of-the-poisoned-patient#H26755739\" class=\"medical medical_review\">&quot;Gastrointestinal decontamination of the poisoned patient&quot;, section on 'Evidence of efficacy and adverse effects'</a>.)</p><p>The recommendation for AC administration following <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> overdose derives from indirect evidence of benefit in volunteers, animal studies, and evidence of benefit following ingestions of other medications. Because of adverse effects, such as vomiting and dehydration, the combination of a cathartic (eg, <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">sorbitol</a>) and AC should be used sparingly, if at all, and only a single dose of a cathartic should be given to any patient. (See <a href=\"topic.htm?path=gastrointestinal-decontamination-of-the-poisoned-patient#H18993761\" class=\"medical medical_review\">&quot;Gastrointestinal decontamination of the poisoned patient&quot;, section on 'Activated charcoal'</a> and <a href=\"topic.htm?path=gastrointestinal-decontamination-of-the-poisoned-patient#H18993978\" class=\"medical medical_review\">&quot;Gastrointestinal decontamination of the poisoned patient&quot;, section on 'Cathartics'</a>.)</p><p>We recommend <strong>not</strong> performing gastric emptying by gastric lavage or by syrup of ipecac-induced emesis in patients who ingest <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>. This recommendation is based on randomized controlled trials showing minimal benefit and possible risk to patients who undergo gastric emptying after poisoning. (See <a href=\"topic.htm?path=gastrointestinal-decontamination-of-the-poisoned-patient\" class=\"medical medical_review\">&quot;Gastrointestinal decontamination of the poisoned patient&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">NALOXONE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=naloxone-drug-information\" class=\"drug drug_general\">Naloxone</a> administration has reversed respiratory depression and coma following <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning in some patients [<a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/5-7\" class=\"abstract_t\">5-7</a>]. Patients with deep coma and respiratory depression should receive intravenous naloxone (0.1 <span class=\"nowrap\">mg/kg,</span> maximum initial dose: 2 mg). Some patients may require total doses of naloxone approaching 10 mg to fully reverse symptoms of respiratory depression [<a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/5\" class=\"abstract_t\">5</a>]. Patients who improve after naloxone administration still warrant hospital admission and intensive monitoring for recurrence of symptoms. If altered mental status and respiratory depression recur, we suggest the administration of additional intermittent doses, as needed, rather than a continuous infusion.</p><p><a href=\"topic.htm?path=naloxone-drug-information\" class=\"drug drug_general\">Naloxone</a> administration should not delay the timely provision of supportive care (eg, bag-valve-mask ventilation with 100 percent oxygen) in patients who do not initially respond.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">OTHER TOXINS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, over-the-counter cough formulations frequently contain other pharmaceutical agents whose toxicity may complicate dextromethorphan poisoning, such as <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, <a href=\"topic.htm?path=chlorpheniramine-drug-information\" class=\"drug drug_general\">chlorpheniramine</a> or other antihistamines, or <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a>.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Acetaminophen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> levels in the possible toxic range, based on the Rumack-Matthew nomogram (<a href=\"image.htm?imageKey=EM%2F83590\" class=\"graphic graphic_figure graphicRef83590 \">figure 1</a>) should receive oral or intravenous antidote therapy with N-acetylcysteine. (See <a href=\"topic.htm?path=management-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Management of acetaminophen (paracetamol) poisoning in children and adolescents&quot;</a> and <a href=\"topic.htm?path=acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Antihistamines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> intoxication is frequently complicated by anticholinergic poisoning caused by coingestion of antihistamines in the cough and cold formulation. (See <a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning#H19880406\" class=\"medical medical_review\">&quot;Over-the-counter cough and cold preparations: Approach to pediatric poisoning&quot;, section on 'Antihistamines'</a>.)</p><p>Both <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> and anticholinergic poisoning have similar presenting signs and symptoms that makes treatment decisions difficult. (See <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis#H16\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;, section on 'Differential diagnosis'</a> and <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis#H9\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;, section on 'Clinical features'</a>.)</p><p>Agitation and delirium caused by anticholinergic poisoning is initially treated with benzodiazepines (<a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a> 0.1 mg; maximum dose: 2 mg). Some experts recommend that patients with anticholinergic poisoning manifesting both peripheral signs (eg, flushing, dry skin, hyperthermia) and central effects (agitated delirium, seizures) receive <a href=\"topic.htm?path=physostigmine-drug-information\" class=\"drug drug_general\">physostigmine</a>. However, this recommendation is controversial and consultation with a medical toxicologist or regional poison center should be obtained before physostigmine is given. (See <a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">&quot;Anticholinergic poisoning&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Phenylephrine and similar decongestants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">Phenylephrine</a> and other alpha1 adrenergic agonists can precipitate a hypertensive emergency in overdose that may require emergent administration of intravenous antihypertensive medication (eg, <a href=\"topic.htm?path=phentolamine-drug-information\" class=\"drug drug_general\">phentolamine</a> 0.1 <span class=\"nowrap\">mg/kg;</span> maximum dose: 5 mg). (See <a href=\"topic.htm?path=management-of-hypertensive-emergencies-and-urgencies-in-children#H10\" class=\"medical medical_review\">&quot;Management of hypertensive emergencies and urgencies in children&quot;, section on 'Blood pressure management'</a> and <a href=\"topic.htm?path=drugs-used-for-the-treatment-of-hypertensive-emergencies#H13\" class=\"medical medical_review\">&quot;Drugs used for the treatment of hypertensive emergencies&quot;, section on 'Phentolamine'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">DISPOSITION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with uncomplicated <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> (DXM) poisoning have resolution of symptoms within four to six hours after ingestion [<a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/8-10\" class=\"abstract_t\">8-10</a>]. Patients with complicated courses marked by hyperthermia, rhabdomyolysis, or serotonin syndrome warrant intensive care until symptoms resolve. (See <a href=\"#H2\" class=\"local\">'Supportive care'</a> above.)</p><p>Patients who are suicidal require psychiatric evaluation prior to discharge and should also be carefully evaluated for coingestions including the measurement of an <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> level.</p><p>Patients who are asymptomatic for six hours after ingestion of DXM, who have nontoxic <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> levels, and who are not suicidal, may be discharged home.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">ADDITIONAL RESOURCES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical <span class=\"nowrap\">and/or</span> medical toxicologists available for bedside consultation <span class=\"nowrap\">and/or</span> inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its <a href=\"http://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html&amp;token=vYXClxsD0hnrf4M8kYcoD1kMICrGjKQRRaFc8pA0pw9qlhpVmsmYh2e3Gi7webw9H9uSzH3nipQ0rPpTLYBWhGP+/wpQqUegRzvggwgKA6s=&amp;TOPIC_ID=6492\" target=\"_blank\" class=\"external\">website</a>.</p><p class=\"headingAnchor\" id=\"H1764034039\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: General measures for acute poisoning treatment&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-treatment-of-acute-poisoning-caused-by-specific-agents-other-than-drugs-of-abuse\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical features and diagnosis of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning are discussed separately. (See <a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Dextromethorphan abuse and poisoning: Clinical features and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning is primarily supportive. In addition, to careful assessment and support of airway, breathing, and circulation as needed, the clinician should anticipate and aggressively manage agitation, hyperthermia, rhabdomyolysis, <span class=\"nowrap\">and/or</span> serotonin syndrome when they occur. (See <a href=\"#H2\" class=\"local\">'Supportive care'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that patients who ingest dextromethorphan-containing medicines and who present within one hour of known or suspected ingestion receive activated charcoal (AC) (1 <span class=\"nowrap\">g/kg;</span> maximum dose: 50 g) by mouth or nasogastric tube (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should <strong>not</strong> be performed solely for the purpose of giving charcoal. (See <a href=\"#H7\" class=\"local\">'Gastrointestinal decontamination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We recommend that patients who ingest <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> <strong>not</strong> undergo gastric emptying procedures (<a href=\"grade.htm?i=2\" class=\"grade\">Grade 1B</a>). (See <a href=\"#H7\" class=\"local\">'Gastrointestinal decontamination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with deep coma and respiratory depression should receive intravenous <a href=\"topic.htm?path=naloxone-drug-information\" class=\"drug drug_general\">naloxone</a> (0.1 <span class=\"nowrap\">mg/kg,</span> maximum initial dose: 2 mg). Some patients may require total doses of naloxone approaching 10 mg to adequately reverse symptoms. Naloxone administration should not delay the timely provision of supportive care (eg, bag-valve-mask ventilation with 100 percent oxygen) in patients with respiratory depression. (See <a href=\"#H8\" class=\"local\">'Naloxone'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In addition to <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, over-the-counter cough formulations frequently contain other pharmaceutical agents (eg, <a href=\"topic.htm?path=chlorpheniramine-drug-information\" class=\"drug drug_general\">chlorpheniramine</a> or other antihistamines, <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a>) whose toxicity may complicate dextromethorphan poisoning and require specific treatment. (See <a href=\"#H9\" class=\"local\">'Other toxins'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/1\" class=\"nounderline abstract_t\">Kirages TJ, Sul&eacute; HP, Mycyk MB. Severe manifestations of coricidin intoxication. Am J Emerg Med 2003; 21:473.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/2\" class=\"nounderline abstract_t\">Graudins A, Fern RP. Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan containing cough and cold syrup. J Toxicol Clin Toxicol 1996; 34:351.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/3\" class=\"nounderline abstract_t\">Warden CR, Diekema DS, Robertson WO. Dystonic reaction associated with dextromethorphan ingestion in a toddler. Pediatr Emerg Care 1997; 13:214.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/4\" class=\"nounderline abstract_t\">Henretig F, Cugini D, Dubin D. Dextromethorphan overdose in children. Vet Hum Toxicol 1988; 3:364.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/5\" class=\"nounderline abstract_t\">Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med 1995; 13:174.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/6\" class=\"nounderline abstract_t\">Schneider SM, Michelson EA, Boucek CD, Ilkhanipour K. Dextromethorphan poisoning reversed by naloxone. Am J Emerg Med 1991; 9:237.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/7\" class=\"nounderline abstract_t\">Shaul WL, Wandell M, Robertson WO. Dextromethorphan toxicity: reversal by naloxone. Pediatrics 1977; 59:117.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/8\" class=\"nounderline abstract_t\">Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care 2004; 20:858.</a></li><li class=\"breakAll\">Boyer E. Dissociative agents: Phencyclidine, ketamine, dextromethorphan. In: Haddad and Wincehster's Clinical Management of Poisoning and Drug Overdose, 4th, Shannon MW, Borron SW, Burns MJ (Eds), Saunders, Philadelphia 2007. p.776.</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-poisoning-treatment/abstract/10\" class=\"nounderline abstract_t\">LoVecchio F, Pizon A, Matesick L, O'Patry S. Accidental dextromethorphan ingestions in children less than 5 years old. J Med Toxicol 2008; 4:251.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6492 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H1114943080\" id=\"outline-link-H1114943080\">CLINICAL FEATURES AND DIAGNOSIS</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">SUPPORTIVE CARE</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Restraint and sedation</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Hyperthermia</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Rhabdomyolysis</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Serotonin syndrome</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">GASTROINTESTINAL DECONTAMINATION</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">NALOXONE</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">OTHER TOXINS</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Acetaminophen</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Antihistamines</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Phenylephrine and similar decongestants</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">DISPOSITION</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">ADDITIONAL RESOURCES</a></li><li><a href=\"#H1764034039\" id=\"outline-link-H1764034039\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"EM/6492|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=EM/83590\" class=\"graphic graphic_figure\">- Acetaminophen poisoning nomogram</a></li></ul></li><li><div id=\"EM/6492|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=EM/73400\" class=\"graphic graphic_table\">- Serotonin syndrome - Rapid overview</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-diagnosis\" class=\"medical medical_review\">Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">Anticholinergic poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-child-with-occult-toxic-exposure\" class=\"medical medical_review\">Approach to the child with occult toxic exposure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=assessment-and-emergency-management-of-the-acutely-agitated-or-violent-adult\" class=\"medical medical_review\">Assessment and emergency management of the acutely agitated or violent adult</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=convulsive-status-epilepticus-in-adults-classification-clinical-features-and-diagnosis\" class=\"medical medical_review\">Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis\" class=\"medical medical_review\">Dextromethorphan abuse and poisoning: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drugs-used-for-the-treatment-of-hypertensive-emergencies\" class=\"medical medical_review\">Drugs used for the treatment of hypertensive emergencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=emergency-department-evaluation-of-acute-onset-psychosis-in-children\" class=\"medical medical_review\">Emergency department evaluation of acute onset psychosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ethanol-intoxication-in-children-clinical-features-evaluation-and-management\" class=\"medical medical_review\">Ethanol intoxication in children: Clinical features, evaluation, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastrointestinal-decontamination-of-the-poisoned-patient\" class=\"medical medical_review\">Gastrointestinal decontamination of the poisoned patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-approach-to-drug-poisoning-in-adults\" class=\"medical medical_review\">General approach to drug poisoning in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=heat-stroke-in-children\" class=\"medical medical_review\">Heat stroke in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ketamine-poisoning\" class=\"medical medical_review\">Ketamine poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mdma-ecstasy-intoxication\" class=\"medical medical_review\">MDMA (ecstasy) intoxication</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">Management of acetaminophen (paracetamol) poisoning in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-convulsive-status-epilepticus-in-children\" class=\"medical medical_review\">Management of convulsive status epilepticus in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-hypertensive-emergencies-and-urgencies-in-children\" class=\"medical medical_review\">Management of hypertensive emergencies and urgencies in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning\" class=\"medical medical_review\">Over-the-counter cough and cold preparations: Approach to pediatric poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-children-and-adolescents\" class=\"medical medical_review\">Phencyclidine (PCP) intoxication in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-and-treatment-of-heme-pigment-induced-acute-kidney-injury\" class=\"medical medical_review\">Prevention and treatment of heme pigment-induced acute kidney injury</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">Serotonin syndrome (serotonin toxicity)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=severe-nonexertional-hyperthermia-classic-heat-stroke-in-adults\" class=\"medical medical_review\">Severe nonexertional hyperthermia (classic heat stroke) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">Society guideline links: General measures for acute poisoning treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-treatment-of-acute-poisoning-caused-by-specific-agents-other-than-drugs-of-abuse\" class=\"medical medical_society_guidelines\">Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse</a></li></ul></div></div>","javascript":null}